Skip to search.
 FTSE 100 Down 0.90%

MannKind Corp. (MNKD)

-NasdaqGM
1.46 Up 0.01(0.34%) 19:13 - Nasdaq Real Time Price
Prev Close:1.45
Open:1.43
Bid:1.45 x 3000
Ask:1.46 x 13400
1y Target Est:1.40
Beta:2.9885
Next Earnings Date: 9-May-16MNKD Earnings announcement
Day's Range:1.38 - 1.46
52wk Range:0.64 - 7.32
Volume:1,217,085
Avg Vol (3m):6,147,980
Market Cap:624.40m
P/E (ttm):N/A
EPS (ttm):-0.32
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for MNKD at this time.

Comparison

Symbol% ChgMkt Cap
MNKDUp 0.34%624.40m
LLYDown 0.43%81.24b
GSKUp 0.15%104.92b
NVODown 1.35%140.37b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.20
Quarterly EPS Est (Mar-16) :-0.04
Mean Recommendation*:2.8
PEG Ratio (5 yr expected):-0.27

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes patients in the United States. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback